|Title||Bone, inflammation, and inflammatory bowel disease.|
|Publication Type||Journal Article|
|Year of Publication||2011|
|Authors||Agrawal M, Arora S, Li J, Rahmani R, Sun L, Steinlauf AF, Mechanick JI, Zaidi M|
|Journal||Curr Osteoporos Rep|
|Date Published||2011 Dec|
|Keywords||Cell Communication, Humans, Inflammation, Inflammatory Bowel Diseases, Osteoblasts, Osteoclasts, Osteoporosis, Signal Transduction, Vitamin D Deficiency|
Osteoporosis is a leading cause of morbidity in patients with inflammatory bowel disease (IBD). Bone loss is an early systemic process and occurs even before clinical disease manifests. Bone disease is attributed to vitamin D deficiency, steroid use, and/or systemic inflammation. In this review, we discuss the molecular pathways of bone loss mediated by inflammatory cytokines and other mediators. Further research will hopefully clarify the mechanisms of inflammation-induced bone loss in IBD and guide effective treatment modalities.
|Alternate Journal||Curr Osteoporos Rep|
Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.